[Cefotetan treatment of suppurative bronchopulmonary syndromes sustained by anaerobic germs].
The Authors have analyzed the effect of Cefotetan in 20 patients affected by bronchopulmonary pathologies supported by anaerobic bacterium. During 7 days doses of 50 mg. pro Kg/pro die were given. From beginning to end of the treatment clinical, hematochemical and radiological data were evaluated. Bacteriological analysis was made on samples drawn with BFS according to a traditional method and with microbiology specimen brush. Almost all the patients (95%) realized improvements in clinical symptomatology and in radiological picture.
Caputi
M
M
Istituto di Clinica Tisiologica e Malattie dell'Apparato Respiratorio, I Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli.
Guarino
C
C
Cautiero
V
V
Sorrentino
L
L
Cione
P
P
Cuccurullo
S
S
Tarantino
C
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D001421:Bacteria, Anaerobic / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D001431:Bacteriological Techniques / Q000295:instrumentation; D001987:Bronchiectasis / Q000188:drug therapy* / Q000382:microbiology; D015313:Cefotetan / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D015313:Cefotetan
Trattamento con cefotetan delle sindromi suppurative bronco-polmonari sostenute da germi anaerobi.